Old Drug, New Rules: Where Methotrexate Fits in Modern Still’s Disease Care
A new narrative review repositions methotrexate as a complementary, steroid-sparing option in Still's disease while confirming that early interleukin-1 or ...
A new narrative review repositions methotrexate as a complementary, steroid-sparing option in Still's disease while confirming that early interleukin-1 or ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine